Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have made an important advancement in the field of single-cell transcriptomics by developing a novel bead design that reduces errors in DNA synthesis and improves the reliability of gene expression measurements.

DNA strand

Single-cell transcriptomics has revolutionised the study of cellular diversity and function by enabling gene expression analysis at single-cell resolution. The technique is crucial for understanding how different cells function, how they communicate, and how they contribute to various biological processes and diseases.

However, technical errors in the synthesis of oligonucleotides (short DNA sequences)—particularly in droplet-based methods such as Drop-seq and 10x Chromium—frequently lead to inaccurate results, causing researchers to discard valuable data. These synthesis errors obscure identification of the cell barcode (which identifies the cell) and UMI (unique molecular identifier) resulting in substantial data loss and limiting sequencing efficiency.

Published in Communications Biology, Associate Professor Adam Cribbs and Dr. Jianfeng Sun at the Botnar Institute for Musculoskeletal Sciences identified a major source of error: premature truncation of UMIs before sequencing.  To address this, they developed a novel bead design that improves the reliability of gene expression measurements by mitigating truncation errors in UMIs prior to sequencing.

They added what they call an “anchor” between two important parts of the sequence: between the barcode and UMI. This anchor provides a clear demarcation point, enhancing UMI recognition and minimising synthesis errors.

The work builds on the Oxford team’s previous homotrimer UMI error correction strategy, which focused on errors arising after sequencing. In contrast, the new anchor-interposed approach tackles UMI errors at the pre-sequencing stage, further advancing long-read transcriptomics. 

 

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website.

 

 

Similar stories

Exceptional early-career researchers awarded 2026 European Research Council Starting Grants

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

How body fat is stored across organs may reveal hidden health risks, study suggests

Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Four Oxford researchers recognised in the 2026 Royal Society Awards

The annual Royal Society Awards recognise outstanding contributions to scientific discovery, public engagement and research culture. Of the 27 awards for 2025-26, announced today, four honour Oxford University researchers.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds

An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.

Brain imaging study reveals how we decide whether we are in control

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.